Resources
Top 100 Part D Drug Pages: #1 Prescriber by State
Each page shows the #1 prescriber in all 50 states and DC for one drug, using brand + generic pairs.
Drug ranking year: 2024 (Q1-Q4). Prescriber ranking year: 2023.
Home / Data Tools / Part D Prescribers / Top 100 Drug Pages
All Top 100 Drug Pages
Drug list ranked by total Part D spending in 2024 (Q1-Q4). Each page shows 2023 #1 prescribers by state and DC.
- #1 Eliquis (Apixaban) — $20,775,502,067.48 total spending
- #2 Ozempic (Semaglutide) — $12,970,782,478.00 total spending
- #3 Jardiance (Empagliflozin) — $11,436,354,934.00 total spending
- #4 Mounjaro (Tirzepatide) — $6,337,145,320.00 total spending
- #5 Xarelto (Rivaroxaban) — $6,232,421,154.00 total spending
- #6 Trulicity (Dulaglutide) — $5,454,338,505.00 total spending
- #7 Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) — $5,294,493,957.27 total spending
- #8 Farxiga (Dapagliflozin Propanediol) — $5,290,714,937.00 total spending
- #9 Humira(Cf) Pen (Adalimumab) — $4,328,873,762.41 total spending
- #10 Revlimid (Lenalidomide) — $4,179,625,244.10 total spending
- #11 Entresto (Sacubitril/Valsartan) — $4,020,374,794.00 total spending
- #12 Januvia (Sitagliptin Phosphate) — $3,808,011,912.00 total spending
- #13 Biktarvy (Bictegrav/Emtricit/Tenofov Ala) — $3,456,303,359.63 total spending
- #14 Xtandi (Enzalutamide) — $3,401,164,480.34 total spending
- #15 Stelara (Ustekinumab) — $3,378,044,024.47 total spending
- #16 Vyndamax (Tafamidis) — $2,830,811,857.09 total spending
- #17 Enbrel Sureclick (Etanercept) — $2,337,191,847.85 total spending
- #18 Myrbetriq (Mirabegron) — $2,297,100,017.31 total spending
- #19 Imbruvica (Ibrutinib) — $2,266,398,542.00 total spending
- #20 Pomalyst (Pomalidomide) — $2,149,966,456.28 total spending
- #21 Ofev (Nintedanib Esylate) — $2,086,398,979.00 total spending
- #22 Jakafi (Ruxolitinib Phosphate) — $2,082,845,241.00 total spending
- #23 Ibrance (Palbociclib) — $2,035,022,061.34 total spending
- #24 Linzess (Linaclotide) — $1,982,021,464.00 total spending
- #25 Ingrezza (Valbenazine Tosylate) — $1,956,648,355.00 total spending
- #26 Invega Sustenna (Paliperidone Palmitate) — $1,878,161,553.16 total spending
- #27 Dupixent Pen (Dupilumab) — $1,804,700,763.00 total spending
- #28 Skyrizi Pen (Risankizumab-Rzaa) — $1,781,273,547.78 total spending
- #29 Brukinsa (Zanubrutinib) — $1,724,519,196.21 total spending
- #30 Repatha Sureclick (Evolocumab) — $1,709,612,955.00 total spending
- #31 Calquence (Acalabrutinib Maleate) — $1,701,974,921.00 total spending
- #32 Tagrisso (Osimertinib Mesylate) — $1,627,109,177.36 total spending
- #33 Creon (Lipase/Protease/Amylase) — $1,493,560,029.00 total spending
- #34 Erleada (Apalutamide) — $1,386,301,873.27 total spending
- #35 Rinvoq (Upadacitinib) — $1,385,518,334.25 total spending
- #36 Breo Ellipta (Fluticasone/Vilanterol) — $1,360,567,523.00 total spending
- #37 Restasis (Cyclosporine) — $1,289,781,397.00 total spending
- #38 Opsumit (Macitentan) — $1,231,870,414.00 total spending
- #39 Cabometyx (Cabozantinib S-Malate) — $1,216,725,023.00 total spending
- #40 Xifaxan (Rifaximin) — $1,158,129,706.00 total spending
- #41 Vraylar (Cariprazine HCl) — $1,136,007,366.00 total spending
- #42 Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) — $1,130,141,185.00 total spending
- #43 Tradjenta (Linagliptin) — $1,127,633,749.19 total spending
- #44 Austedo (Deutetrabenazine) — $1,066,901,470.47 total spending
- #45 Verzenio (Abemaciclib) — $1,056,832,558.00 total spending
- #46 Otezla (Apremilast) — $1,045,029,751.00 total spending
- #47 Nubeqa (Darolutamide) — $998,066,130.12 total spending
- #48 Tresiba Flextouch U-200 (Insulin Degludec) — $973,895,430.60 total spending
- #49 Gemtesa (Vibegron) — $945,116,882.85 total spending
- #50 Venclexta (Venetoclax) — $941,720,712.90 total spending
- #51 Uptravi (Selexipag) — $908,772,074.01 total spending
- #52 Spiriva Respimat (Tiotropium Bromide) — $877,227,399.79 total spending
- #53 Lenvima (Lenvatinib Mesylate) — $875,815,079.90 total spending
- #54 Rexulti (Brexpiprazole) — $861,397,258.40 total spending
- #55 Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) — $819,265,525.10 total spending
- #56 Cosentyx Sensoready (2 Pens) (Secukinumab) — $817,602,381.10 total spending
- #57 Shingrix (Varicella-Zoster Ge/As01b/PF) — $775,620,793.20 total spending
- #58 Kisqali (Ribociclib Succinate) — $775,562,471.94 total spending
- #59 Arexvy (Rsvpref3 Antigen/As01e/PF) — $774,220,218.90 total spending
- #60 Prolia (Denosumab) — $771,854,677.50 total spending
- #61 Epclusa (Sofosbuvir/Velpatasvir) — $758,041,570.23 total spending
- #62 Atorvastatin Calcium (Atorvastatin Calcium) — $756,511,972.40 total spending
- #63 Tyvaso Dpi (Treprostinil) — $728,752,454.61 total spending
- #64 Trikafta (Elexacaftor/Tezacaftor/IVacaft) — $725,020,560.00 total spending
- #65 Vascepa (Icosapent Ethyl) — $724,195,179.00 total spending
- #66 Oxervate (Cenegermin-Bkbj) — $714,549,320.33 total spending
- #67 Janumet (Sitagliptin Phos/Metformin HCl) — $709,239,361.48 total spending
- #68 Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) — $699,149,923.21 total spending
- #69 Adempas (Riociguat) — $694,246,753.40 total spending
- #70 Abiraterone Acetate (Abiraterone Acetate) — $692,961,574.92 total spending
- #71 Brilinta (Ticagrelor) — $685,522,457.83 total spending
- #72 Promacta (Eltrombopag Olamine) — $672,379,160.60 total spending
- #73 Nuplazid (Pimavanserin Tartrate) — $657,826,492.60 total spending
- #74 Lumigan (Bimatoprost) — $647,232,523.67 total spending
- #75 Abilify Maintena (Aripiprazole) — $644,205,287.30 total spending
- #76 Tivicay (Dolutegravir Sodium) — $629,441,861.03 total spending
- #77 Nurtec ODT (Rimegepant Sulfate) — $625,283,823.70 total spending
- #78 Symbicort (Budesonide/Formoterol Fumarate) — $597,821,570.80 total spending
- #79 Lynparza (Olaparib) — $594,023,445.70 total spending
- #80 Xeljanz XR (Tofacitinib Citrate) — $589,794,982.60 total spending
- #81 Kesimpta Pen (Ofatumumab) — $582,607,939.91 total spending
- #82 Gammagard Liquid (Immun Glob G(IgG)/Gly/IgA Ov50) — $580,810,193.41 total spending
- #83 Orencia Clickject (Abatacept) — $570,276,354.30 total spending
- #84 Triumeq (Abacavir/Dolutegravir/Lamivudi) — $565,947,870.80 total spending
- #85 Taltz Autoinjector (Ixekizumab) — $564,471,357.60 total spending
- #86 Albuterol Sulfate HFA (Albuterol Sulfate) — $552,650,474.20 total spending
- #87 Genvoya (Elviteg/Cob/Emtri/Tenof Alafen) — $552,006,675.10 total spending
- #88 Descovy (Emtricitabine/Tenofov Alafenam) — $544,728,924.20 total spending
- #89 Gabapentin (Gabapentin) — $544,167,162.40 total spending
- #90 Dovato (Dolutegravir Sodium/Lamivudine) — $541,104,087.10 total spending
- #91 Gamunex-C (Immune Globul G/Gly/IgA Avg 46) — $520,791,984.70 total spending
- #92 Sprycel (Dasatinib) — $518,386,097.13 total spending
- #93 Xiidra (Lifitegrast) — $505,353,896.40 total spending
- #94 Privigen (Immun Glob G(IgG)/Pro/IgA 0-50) — $493,878,771.50 total spending
- #95 Orgovyx (Relugolix) — $484,326,163.20 total spending
- #96 Tremfya One-Press (Guselkumab) — $480,785,319.52 total spending
- #97 Abrysvo (Rsv Vacc, Pref A And Pref B/PF) — $467,567,623.80 total spending
- #98 Levothyroxine Sodium (Levothyroxine Sodium) — $464,234,508.10 total spending
- #99 Metoprolol Succinate (Metoprolol Succinate) — $455,984,640.80 total spending
- #100 Stiolto Respimat (Tiotropium Br/Olodaterol HCl) — $448,589,015.90 total spending